| Title | Current Signal Transduction Therapy |
| Abbreviation | Curr. Signal Transduct. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology (Q4); Pharmacology (medical) (Q4) |
| h-index | 22 |
| Overall Rank/Ranking | 24530 |
| SCImago Journal Rank (SJR) | 0.15 |
| Impact Score | 0.68 |
| Publisher | Bentham Science Publishers |
| Country | United Arab Emirates |
| ISSN | 2212389X, 15743624 |
| Best Quartile | Q4 |
| Coverage History | 2007-2024 |
Current Signal Transduction Therapy is a journal covering the technologies/fields/categories related to Endocrinology (Q4); Pharmacology (medical) (Q4). It is published by Bentham Science Publishers. The overall rank of Current Signal Transduction Therapy is 24530. According to SCImago Journal Rank (SJR), this journal is ranked 0.15. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 22. The best quartile for this journal is Q4.
The ISSN of Current Signal Transduction Therapy journal is 2212389X, 15743624. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Signal Transduction Therapy is cited by a total of 50 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Current Signal Transduction Therapy is 0.68, which is computed in 2025 as per its definition. Current Signal Transduction Therapy IF is increased by a factor of 0.1 and approximate percentage change is 17.24% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Current Signal Transduction Therapy is 0.68. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.68 |
| 2023 | 0.58 |
| 2022 | 0.89 |
| 2021 | 0.65 |
| 2020 | 1.45 |
| 2019 | 0.45 |
| 2018 | 0.66 |
| 2017 | 0.22 |
| 2016 | 0.09 |
| 2015 | 0.55 |
| 2014 | 0.51 |
Current Signal Transduction Therapy has an h-index of 22. It means 22 articles of this journal have more than 22 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Signal Transduction Therapy is 2212389X, 15743624. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Signal Transduction Therapy is 24530. According to SCImago Journal Rank (SJR), this journal is ranked 0.15. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.15 |
| 2023 | 0.188 |
| 2022 | 0.176 |
| 2021 | 0.151 |
| 2020 | 0.128 |
| 2019 | 0.142 |
| 2018 | 0.138 |
| 2017 | 0.129 |
| 2016 | 0.232 |
| 2015 | 0.262 |
| 2014 | 0.154 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 24530 |
| 2023 | 20630 |
| 2022 | 20436 |
| 2021 | 21071 |
| 2020 | 25604 |
| 2019 | 22343 |
| 2018 | 22603 |
| 2017 | 23458 |
| 2016 | 16053 |
| 2015 | 14641 |
| 2014 | 20292 |
Current Signal Transduction Therapy is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2007-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Signal Transduction Therapy is Curr. Signal Transduct. Ther.. This abbreviation ('Curr. Signal Transduct. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology (Q4); Pharmacology (medical) (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Signal Transduction Therapy latest impact IF is 0.68. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.45 (2020) and 0.09 (2016), respectively, in the last 11 years. Moreover, its average IS is 0.61 in the previous 11 years.
The Current Signal Transduction Therapy has an SJR (SCImago Journal Rank) of 0.15, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.262 in 2015 and the lowest being 0.128 in 2020. Furthermore, the average SJR of the Current Signal Transduction Therapy over the previous 11-year period stands at 0.61.
The latest h-index of the Current Signal Transduction Therapy is 22.
The Current Signal Transduction Therapy is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.
The Current Signal Transduction Therapy is currently ranked 24530 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 14641 in 2015 and its lowest position of 25604 in 2020.
The standard ISO4 abbreviation for the Current Signal Transduction Therapy is Curr. Signal Transduct. Ther..
Current Signal Transduction Therapy is classified as a journal that the Bentham Science Publishers publishes.
The Current Signal Transduction Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Signal Transduction Therapy is assigned the following International Standard Serial Numbers (ISSN): 2212389X, 15743624.
The best quartile for the Current Signal Transduction Therapy is Q4 (2024).
The Current Signal Transduction Therapy coverage history can be summarized as follows: 2007-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Criminal Justice Review | journal | 10284 | SAGE Publications Inc. | 46 | 1.91 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| Journal of Classical Sociology | journal | 16960 | SAGE Publications Ltd | 31 | 0.68 |
| Discourse | journal | 7536 | Routledge | 70 | 2.75 |
| World Englishes | journal | 7267 | Wiley-Blackwell | 68 | 2.38 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 17452 | Taylor and Francis Ltd. | 27 | 1.17 |
| Sex Education | journal | 6348 | Routledge | 51 | 2.49 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Journal of Immigrant and Refugee Studies | journal | 7357 | Routledge | 39 | 2.17 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.68 |
| 2023 | 0.58 |
| 2022 | 0.89 |
| 2021 | 0.65 |
| 2020 | 1.45 |
| 2019 | 0.45 |
| 2018 | 0.66 |
| 2017 | 0.22 |
| 2016 | 0.09 |
| 2015 | 0.55 |
| 2014 | 0.51 |
